Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Blood (2024) 144 (Supplement 1): 5043.

https://doi.org/10.1182/blood-2024-194268

Published: 2024

Journal Articles

Evaluating Multiple Myeloma Treatment and Clinical-Decision Making with Real-World Data

Jaime Miller, Mark Walker, Dmytro Assonov, Leena Chhun, Kati O'Brien, C. Anthony Blau

Blood (2024) 144 (Supplement 1): 2384.

https://doi.org/10.1182/blood-2024-205813

Published: 2024

Journal Articles

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Mehdi M. Moezi, Mohamad Kanaan, Patrick M. Travis, Tara Graff, Cheng Zheng, Jessa Dunivan, Tiffany Wood, Sophia Essiet, Jessica Faucheaux, Brian Decker, Jennifer Wren, Leena Chhun, Jayne Piboonvaranggoon, Mark Walker, Trudy Buckingham, Joseph Guidi, Shannon Altimari, C. Anthony Blau

Blood (2023) 142 (Supplement 1): 3375.

https://doi.org/10.1182/blood-2023-187234

Published: 2023

Journal Articles

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Piyanuch Kongtim, Mary-Elizabeth M. Percival, Timothy J Martins, Guangrong Qin, Niall Curley, Kelda M. Gardner, Sylvia Chien, Jin Dai, Vivian G. Oehler, C. Anthony Blau, Paul C. Hendrie, Ryan D. Cassaday, Anna B. Halpern, Bart L. Scott, Roland B. Walter, Heather Smith, Guido Marcucci, Pamela S. Becker

Blood (2022) 140 (Supplement 1): 1200–1202.

https://doi.org/10.1182/blood-2022-165801

Published: 2022

Journal Articles

Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma

Blood (2021) 138 (Supplement 1): 4969.

https://doi.org/10.1182/blood-2021-148399

Published: 2021

Journal Articles

Variation in the Treatment of Multiple Myeloma in the Real World

Joshua Richter, MD, Leena Chhun, B.S., Cheng Zheng, B.S., Jayne Piboonvaranggoon, B.S., Elora Mallick, B.S., Jennifer Wren, B.S., Grace Nam, M.S., Ricardo Lopez Barquilla, PhD, Alexandra Dardac, B.S., Sibel Blau, MD, Francis M. Senecal, MD, Swathi Namburi, MD, Andrew J. Cowan, MD, William I Bensinger, MD, Shaji K. Kumar, MD, Paul G. Richardson, MD, Kenneth Anderson, MD, C. Anthony Blau, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-138705

Published: 2020

Journal Articles

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Blood (2016) 128 (22): 4043.

https://doi.org/10.1182/blood.V128.22.4043.4043

Published: 2016

Journal Articles

Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, Michael W. Schmitt, MD PhD, Zhiyi Xie, PhD, Andrew R Carson, PhD, Bradley Patay, MD, Seyed Sina Khankhajeh, Qi Wei, Ling-Hong Hung, Timothy Martins, PhD, Elihu H. Estey, MD, C. Anthony Blau, MD, Vivian G. Oehler, MD, Ka Yee Yeung, PhD

Blood (2015) 126 (23): 3851.

https://doi.org/10.1182/blood.V126.23.3851.3851

Published: 2015

Journal Articles

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor

Eyayu Belay, Chris P. Miller, Amanda N. Kortum, Beverly Torok-Storb, C. Anthony Blau, David W. Emery

Blood (2015) 125 (6): 1025–1033.

https://doi.org/10.1182/blood-2014-02-555318

Published: 2015

Includes: Supplemental data

Journal Articles

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Pamela S. Becker, MD PhD, Vivian Oehler, MD, Elihu H. Estey, MD, Timothy Martins, PhD, Andrea Perdue, PA-C, Jodie David, RN, Sylvia Chien, Paul C. Hendrie, MD PhD, Fabiana Ostronoff, MD, C. Anthony Blau, MD

Blood (2014) 124 (21): 3748.

https://doi.org/10.1182/blood.V124.21.3748.3748

Published: 2014

Journal Articles

Big Data Approach to Identify Molecular Basis for Drug Sensitivity Phenotypes in Acute Myeloid Leukemia

Su-In Lee, PhD, Benjamin Logsdon, PhD, Akanksha Saxena, BS, Vivian Oehler, MD, Chris P. Miller, PhD, C. Anthony Blau, MD, Pamela S. Becker, MD PhD

Blood (2014) 124 (21): 265.

https://doi.org/10.1182/blood.V124.21.265.265

Published: 2014

Journal Articles

Characterization Of FLT3 /ITD Resistant Cells and Identification Of Novel Therapeutic Targets Utilizing High Throughput Drug Screening

Katherine Tarlock, MD, C. Anthony Blau, MD, Timothy Martins, PhD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 2522.

https://doi.org/10.1182/blood.V122.21.2522.2522

Published: 2013

Journal Articles

Proof-Of-Concept Study For Precision Medicine With Chromosome Genomic Array Testing (CGAT) For Drug Sensitivity Screening In Acute Myeloid Leukemia

Min Fang, MD, PhD, Scott McElhone, Xin Zhao, MD, Barry E. Storer, PhD, Su-In Lee, Ph.D., C. Anthony Blau, MD, Vivian G. Oehler, MD, Elihu H. Estey, MD, Frederick R. Appelbaum, MD, Pamela S Becker, MD, PhD

Blood (2013) 122 (21): 2578.

https://doi.org/10.1182/blood.V122.21.2578.2578

Published: 2013

Journal Articles

Personalized Approach To Treatment of Acute Myeloid Leukemia Using a High-Throughput Chemosensitivity Assay

Ka Yee Yeung, Ph.D., C. Anthony Blau, MD, Vivian G. Oehler, MD, Su-In Lee, Ph.D., Christopher P. Miller, PhD, Sylvia Chien, Timothy Martins, PhD, Elihu H. Estey, MD, Pamela S. Becker, MD, PhD

Blood (2013) 122 (21): 483.

https://doi.org/10.1182/blood.V122.21.483.483

Published: 2013

Journal Articles

Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling

Linlin Wang, Thomas C. Schulz, Eric S. Sherrer, Derek S. Dauphin, Soojung Shin, Angelique M. Nelson, Carol B. Ware, Mei Zhan, Chao-Zhong Song, Xiaoji Chen, Sandii N. Brimble, Amanda McLean, Maria J. Galeano, Elizabeth W. Uhl, Kevin A. D'Amour, Jonathan D. Chesnut, Mahendra S. Rao, C. Anthony Blau, Allan J. Robins

Blood (2007) 110 (12): 4111–4119.

https://doi.org/10.1182/blood-2007-03-082586

Published: 2007

Includes: Supplemental data

Journal Articles

Growth factor receptors as regulators of hematopoiesis

Michael A. Weinreich, Ingrid Lintmaer, Linlin Wang, H. Denny Liggitt, Michael A. Harkey, C. Anthony Blau

Blood (2006) 108 (12): 3713–3721.

https://doi.org/10.1182/blood-2006-01-012278

Published: 2006

Journal Articles

Epo-Independent Proliferation and Differentiation of Genetically Modified Erythroid Progenitor Cells Using a Chemical Inducer of Dimerization.

Chris P. Miller, PhD, Songmao Zheng, C. Anthony Blau, MD

Blood (2006) 108 (11): 1159.

https://doi.org/10.1182/blood.V108.11.1159.1159

Published: 2006

Journal Articles

NIH-Funded Research Using Human Embryonic Stem Cells.

C. Anthony Blau, MD, Angelique Nelson, BS, Carol B. Ware, PhD

Blood (2005) 106 (11): 4232.

https://doi.org/10.1182/blood.V106.11.4232.4232

Published: 2005

Journal Articles

Receptor Specificity in the Self-Renewal, Survival and Differentiation of Hematopoietic Stem and Progenitor Cells In Vitro and In Vivo.

Ingrid Lintmaer, MD, Michael A. Weinreich, BS, Linlin Wang, PhD, Denny Liggitt, PhD, Michael Harkey, PhD, C. Anthony Blau, MD

Blood (2005) 106 (11): 3163.

https://doi.org/10.1182/blood.V106.11.3163.3163

Published: 2005

Journal Articles

Expansion of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch.

Linlin Wang, MD, PhD, Brent Wood, MD, Greg Levin, C. Anthony Blau, MD

Blood (2005) 106 (11): 3044.

https://doi.org/10.1182/blood.V106.11.3044.3044

Published: 2005

NARROW

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Evaluating Multiple Myeloma Treatment and Clinical-Decision Making with Real-World Data

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma

Variation in the Treatment of Multiple Myeloma in the Real World

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Big Data Approach to Identify Molecular Basis for Drug Sensitivity Phenotypes in Acute Myeloid Leukemia

Characterization Of FLT3 /ITD Resistant Cells and Identification Of Novel Therapeutic Targets Utilizing High Throughput Drug Screening

Proof-Of-Concept Study For Precision Medicine With Chromosome Genomic Array Testing (CGAT) For Drug Sensitivity Screening In Acute Myeloid Leukemia

Personalized Approach To Treatment of Acute Myeloid Leukemia Using a High-Throughput Chemosensitivity Assay

Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling

Growth factor receptors as regulators of hematopoiesis

Epo-Independent Proliferation and Differentiation of Genetically Modified Erythroid Progenitor Cells Using a Chemical Inducer of Dimerization.

NIH-Funded Research Using Human Embryonic Stem Cells.

Receptor Specificity in the Self-Renewal, Survival and Differentiation of Hematopoietic Stem and Progenitor Cells In Vitro and In Vivo.

Expansion of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only